Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 7;69(5):e0188924.
doi: 10.1128/aac.01889-24. Epub 2025 Apr 14.

Combating yellow fever virus with 7-deaza-7-fluoro-2'-C-methyladenosine

Affiliations

Combating yellow fever virus with 7-deaza-7-fluoro-2'-C-methyladenosine

Julia C LeCher et al. Antimicrob Agents Chemother. .

Abstract

Yellow fever virus (YFV) is a deadly zoonotic flavivirus endemic in tropical/sub-tropical Africa and South America transmitted by mosquito vector (Aedes aegypti; Haemagogus leucocelaenus) to humans and non-human primates. There are no approved antiviral agents for YFV. We previously identified 7-deaza-7-fluoro-2'-C-methyladenosine (DFA) with anti-YFV activity. Interestingly, DFA exhibits pan-activity in vitro against flaviviruses, such as dengue, Japanese encephalitis, Zika, and hepatitis C. This study aimed to expand DFA's anti-flavivirus profile. DFA exhibited potent sub-micromolar anti-YFV activity in vitro against both the vaccine strain (YFV-17D) and a viscerotropic clinical YFV isolate (DakH1279) concomitantly with low cellular cytotoxicity and no notable mitochondrial toxicity. In vivo, efficacy was assessed against both YFV-17DD and a human clinical isolate in A129 and AG129 mouse flavivirus infection models, respectively. DFA significantly reduced virus replication in the livers of YFV-infected mice and the hallmarks of YFV-induced liver damage, including alanine transaminase levels and indocyanine green clearance. Collectively, this work identifies DFA as a potent YFV inhibitor and lays the groundwork for further therapeutic development as a YFV and, potentially, pan-flavivirus therapeutic.

Keywords: 2-FBU; DFA; antiviral agents; flavivirus; nucleoside analogs; yellow fever virus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig 1
Fig 1
Chemical structures of compounds studied herein: A) DFA, B) 2-FBU, and C) sofosbuvir.
Fig 2
Fig 2
Molecular model predicting the binding of DFA-DP in the YFV RdRp catalytic pocket. Active site residues predicted to be involved in DFA-DP binding are highlighted. Shown residues: F atom of the DFA halogen bonds (dashed line) with E460 of the active site. Manganese co-factors (purple) bind residues D667 and N612 of the active site.
Fig 3
Fig 3
DFA reduces levels of infectious YFV yields in Huh-7 cells. (A, B) Huh-7 cells were infected with 260 FFU of YFV-17D (A) or 500 FFU YFV-Dak1279 (B) in a 96-well plate at 90% confluency. (A) After a 2 h incubation, the virus was removed, and cells were treated with twofold serially diluted compound (0–10 µM) in 1% methyl cellulose. After 3 days, cells were fixed, and foci were detected by ELISpot assay. (B) After a 2 h incubation, the virus was removed, and the cells were treated with twofold serially diluted compound (0–10 µM). After 2 days, infected cell supernatants were transferred to a new 96-well plate of Huh-7 cells to quantify infectious virus via foci-forming assay. (A, B) Foci were enumerated using an ImmunoSpot CTL reader, and EC50/EC90 values were calculated by linear regression on GraphPad Prism. n = 6. Shown mean ± standard error of the mean.
Fig 4
Fig 4
DFA’s anti-YFV-17DD activity in A129 mice. Equal numbers of male and female A129 mice aged 8–10 weeks (six mice in total) were infected i.p. with 106 PFU of YFV-17DD in the presence or absence of 10 mg/kg of DFA, injected i.v. 1 h before infection, and every 24 h for 3 days thereafter. Control mock and mock + DFA groups had five mice (three males, two females; n = 5 per group). A) Liver alanine aminotransferase (ALT) levels measured by colorimetric assay from murine sera, expressed as U/mL. Statistical differences among groups were assayed by one-way ANOVA plus Dunnett’s multiple-comparison test. B) Indocyanine green (ICG) clearance on day 3 before euthanasia. Mice were administered 20 mg/kg ICG 20 m before euthanasia. After euthanasia, blood was collected from the vena cava; serum was isolated; and ICG levels were quantified by spectrophotometry. A, B) Statistical differences between groups were determined by one-way ANOVA plus Dunnett’s multiple-comparison test. Shown mean ± standard error of the mean (SEM); ****P > 0.0001. C) qRT-PCR to assess viral load in the murine liver tissue 3 dpi, following euthanasia. Statistical significance between groups assessed by two-tailed unpaired Student t-test. Shown mean ± SEM; *P = 0.0128.
Fig 5
Fig 5
DFA’s anti-wt-YFV activity in AG129 mice. Equal numbers of male and female AG129 mice (n = 6) aged 8–9 weeks were infected i.p. with 103 PFU of clinical YFV isolate WT306. At 1 hpi and every 24 h thereafter, mice were administered i.v. 10 mg/kg of DFA or saline (vehicle control) for 5 days after which mice were sacrificed, and blood and tissues were collected and analyzed. An uninfected mock group with three males and two female mice was used as a negative control (n = 5). (A) Quantification of the total circulating leukocytes. Leukocytes were isolated from the murine blood collected from the vena cava and counted. Mean counts from the YFV-infected group were compared with mean counts from mock or YFV + DFA groups by one-way ANOVA plus Šídák’s multiple-comparison test. Shown, mean ± standard error of the mean (SEM); *P = 0.019 (mock vs YFV + vehicle), *P = 0.03 (YFV + vehicle vs YFV + DFA). (B) Liver alanine aminotransferase (ALT) levels measured by colorimetric assay from murine sera, expressed as U/mL. Statistical differences were assayed by one-way ANOVA plus Kruskal–Wallis multiple-comparison test. Shown mean ± SEM; *P = 0.03 (mock vs YFV + vehicle). (C) Indocyanine green (ICG) clearance on day 5 before euthanasia. Mice were administered 20 mg/kg ICG 20 min before euthanasia. After euthanasia, blood was collected from the vena cava; serum was isolated; and ICG levels were quantified by spectrophotometry. Statistical differences between groups were determined by one-way ANOVA plus Dunnett’s multiple-comparison test. Shown mean ± SEM; **P = 0.036 (mock vs YFV + vehicle), **P = 0.0075 (YFV + vehicle vs YFV + DFA). (D) qRT-PCR to assess viral load in liver tissue. Statistical significance between groups assessed by two-tailed unpaired Student’s t-test. Shown mean ± SEM; *P = 0.02. (E) Quantification of infectious viral particles in liver tissues via plaque assay on Vero cells, expressed as PFU/mL. Statistical significance between groups assessed by two-tailed unpaired Student’s t-test. Shown mean ± SEM; ***P = 0.0004. (F) Histological grading of inflammatory infiltrates in murine livers. Statistical differences between groups were determined by one-way ANOVA plus Dunnett’s multiple-comparison test. Shown mean ± SEM; ***P = 0.0006 (mock vs YFV + vehicle), **P = 0.0081 (YFV + vehicle vs YFV + DFA). G–I) H&E-stained liver slice micrographs of (G) mock, (H) YFV + vehicle, and (I) YFV + DFA. Scale bar: 50 µM.

References

    1. Organization PAHO-WH . 2018. Epidemiological update: yellow fever. Available from: https://www3.paho.org/hq/index.php?option=com_docman&view=download&categ...
    1. Organization WH . 2017. World health organization initiative: eliminate yellow fever (eye) epidemics 2017 – 2026. Available from: https://www.who.int/initiatives/eye-strategy#:~:text=The%20EYE%20strateg...
    1. Prevention CfDCa . Yellow fever. https://www.cdc.gov/yellow-fever/index.html.
    1. Gubler DJ, Kuno G, Markoff L. 2007. Flaviviruses, p 1153–1252. In Knipe DM, Howey P (ed), Fields virology. Vol. 1. Lippincott Williams & Wilkins, Philadelphia, PA.
    1. Servadio JL, Muñoz-Zanzi C, Convertino M. 2021. Estimating case fatality risk of severe Yellow Fever cases: systematic literature review and meta-analysis. BMC Infect Dis 21:819. doi:10.1186/s12879-021-06535-4 - DOI - PMC - PubMed

Publication types

LinkOut - more resources